Literature DB >> 8540727

Biochemical basis for increased susceptibility to Cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity.

D B Mendel1, D B Barkhimer, M S Chen.   

Abstract

It has been observed that herpes simplex virus mutants with deficient or altered thymidine kinase activity are more susceptible to Cidofovir (CDV; 1-[(S)-3-hydroxy-2-(phosphonomethoxy)propyl]cytosine dihydrate) in tissue culture than are the parental strains. During infection of cells, the elevation of the dCTP pool by thymidine kinase mutant viruses is less than that induced by the wild-type virus. The competition between CDV diphosphate and dCTP at the viral polymerase is therefore changed in favor of CDV diphosphate, enhancing its activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8540727      PMCID: PMC162892          DOI: 10.1128/AAC.39.9.2120

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers.

Authors:  P A Sherman; J A Fyfe
Journal:  Anal Biochem       Date:  1989-08-01       Impact factor: 3.365

2.  Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys.

Authors:  K F Soike; J L Huang; J Y Zhang; R Bohm; M J Hitchcock; J C Martin
Journal:  Antiviral Res       Date:  1991-07       Impact factor: 5.970

3.  A new topical treatment for resistant herpes simplex infections.

Authors:  R Snoeck; G Andrei; E De Clercq; M Gerard; N Clumeck; G Tricot; C Sadzot-Delvaux
Journal:  N Engl J Med       Date:  1993-09-23       Impact factor: 91.245

4.  Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient.

Authors:  R G Kost; E L Hill; M Tigges; S E Straus
Journal:  N Engl J Med       Date:  1993-12-09       Impact factor: 91.245

5.  Synthesis and antiviral activity of the nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.

Authors:  J J Bronson; I Ghazzouli; M J Hitchcock; R R Webb; J C Martin
Journal:  J Med Chem       Date:  1989-07       Impact factor: 7.446

6.  Comparative activity of various compounds against clinical strains of herpes simplex virus.

Authors:  G Andrei; R Snoeck; P Goubau; J Desmyter; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

7.  Metabolism of 4'-azidothymidine. A compound with potent and selective activity against the human immunodeficiency virus.

Authors:  M S Chen; R T Suttmann; J C Wu; E J Prisbe
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

8.  An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT.

Authors:  N W Roehm; G H Rodgers; S M Hatfield; A L Glasebrook
Journal:  J Immunol Methods       Date:  1991-09-13       Impact factor: 2.303

9.  Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.

Authors:  H T Ho; K L Woods; J J Bronson; H De Boeck; J C Martin; M J Hitchcock
Journal:  Mol Pharmacol       Date:  1992-01       Impact factor: 4.436

10.  Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.

Authors:  J P Lalezari; W L Drew; E Glutzer; D Miner; S Safrin; W F Owen; J M Davidson; P E Fisher; H S Jaffe
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

View more
  3 in total

Review 1.  Current recommendations for the treatment of genital herpes.

Authors:  D T Leung; S L Sacks
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 2.  Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics.

Authors:  Thessicar E Antoine; Paul J Park; Deepak Shukla
Journal:  Rev Med Virol       Date:  2013-02-26       Impact factor: 6.989

3.  New concepts in understanding genital herpes.

Authors:  Joshua T Schiffer; Lawrence Corey
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.